Quick Answer
Renalytix plc reported Cash And Cash Equivalents At Carrying Value of $4.68 million for the year ending 2024.
- Renalytix plc showed a decrease of -81.0% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
- This data is from Renalytix plc's annual report (Form 10-K), filed with the SEC on September 30, 2024.
- XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2018 to 2024), Renalytix plc's Cash And Cash Equivalents At Carrying Value has grown by 5,607.3%.
- Historical annual values: Fiscal year 2024: $4.68 million | Fiscal year 2023: $24.68 million | Fiscal year 2022: $41.33 million | Fiscal year 2021: $65.13 million | Fiscal year 2020: $13.29 million | Fiscal year 2019: $8.20 million | Fiscal year 2018: $82.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: